Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MorphoSys and Schering AG collaboration yields positive animal data

Aug. 6, 2003

Maxim discusses discovery and development of apoptosis inducers at cancer meeting

Aug. 5, 2003

Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells

Aug. 5, 2003

Bexxar launched in U.S.

Aug. 5, 2003

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Aug. 4, 2003

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Aug. 4, 2003

New nuclear hormone receptor modulators synthesized at BMS

Aug. 4, 2003

Camptothecin encapsulated in cationic liposomes targets tumor blood vessels

Aug. 4, 2003

MOR-201 program discontinued in Q2 at MorphoSys

Aug. 4, 2003

Neovascular targeting therapy developed at Munich Biotech

Aug. 1, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...